002155:SZSEHunan Gold Corporation Limited Analysis
Data as of 2026-05-24 - not real-time
CN¥25.19
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Hunan Gold (002155.SZ) trades at CNY 25.19, just above its 200‑day SMA (CNY 25.07) but well under the 20‑day (CNY 28.30) and 50‑day (CNY 29.68) averages, indicating a neutral‑to‑bearish short‑term bias. The RSI of 31.7 signals oversold conditions, while the MACD is bearish (negative histogram), and volume is slipping, suggesting limited upward momentum in the near term.
Fundamentally, the firm boasts a 43.5% YoY revenue surge, a robust ROE of 22%, negligible debt (DE ratio 0.03) and a healthy cash position, yet margins remain thin (gross 6%). The DCF‑derived fair value of CNY 18.59 is well below the current price, implying a modest overvaluation, but analysts project an 8.5% upside to a target of CNY 27.32. The dividend yield is modest at 0.7% with a low payout ratio (15.8%), supporting dividend sustainability.
Fundamentally, the firm boasts a 43.5% YoY revenue surge, a robust ROE of 22%, negligible debt (DE ratio 0.03) and a healthy cash position, yet margins remain thin (gross 6%). The DCF‑derived fair value of CNY 18.59 is well below the current price, implying a modest overvaluation, but analysts project an 8.5% upside to a target of CNY 27.32. The dividend yield is modest at 0.7% with a low payout ratio (15.8%), supporting dividend sustainability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI indicating oversold conditions
- Bearish MACD and price below short‑term moving averages
- Support level near CNY 24.35 offering downside protection
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth (43.5%) and high ROE (22%)
- Low leverage and solid cash flow supporting operations
- Target price upside of ~8.5% despite current premium
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable dividend with low payout ratio
- Exposure to gold as a defensive commodity asset
- Valuation premium relative to DCF fair value and thin profit margins
Key Metrics & Analysis
Financial Health
Revenue Growth43.50%
Profit Margin3.13%
P/E Ratio22.5
ROE22.17%
ROA14.33%
Debt/Equity0.03
P/B Ratio4.5
Op. Cash FlowCN¥1.5B
Free Cash FlowCN¥756.6M
Technical Analysis
TrendNeutral
RSI31.7
SupportCN¥24.35
ResistanceCN¥31.50
MA 20CN¥28.30
MA 50CN¥29.68
MA 200CN¥25.07
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair ValueCN¥18.59
Target PriceCN¥27.32
Upside/Downside8.46%
GradeOvervalued
TypeBlend
Dividend Yield0.70%
Risk Assessment
Beta0.02
Volatility47.64%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.